Exosome Diagnostic and Therapeutic Market to Reach $2.9 Bn, Globally, by 2030 at 29.4% CAGR: Allied Market Research

News provided by

May 30, 2022, 09:00 ET

Increase in use of multifunctional property of exosome therapy for chronic heart failure, Alzheimer disease, Parkinson's disease, and cancer drive the growth of the global exosome diagnostic and therapeutic market.

PORTLAND, Ore., May 30, 2022 /PRNewswire/ --Allied Market Research published a report, titled, "Exosome Diagnostic and Therapeutic Market by Application (Diagnostic, Therapeutic), by Product (Instrument, Reagent, and Software) by End User (Cancer Institute, Hospital, Diagnostic Center, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030." According to the report, the global exosome diagnostic and therapeutic industry was estimated at $224.34 million in 2020, and is anticipated to hit $2.9 billion by 2030, registering a CAGR of 29.4% from 2021 to 2030.

Download Sample PDF at: https://www.alliedmarketresearch.com/request-sample/1723

Determinants of growth-

Increase in use of multifunctional property of exosome therapy for chronic heart failure, Alzheimer's disease, Parkinson's disease, and cancer drive the growth of the global exosome diagnostic and therapeutic market. On the other hand, rise in demand for drug therapies and surge in R&D activities in the pharmaceutical and biopharmaceutical fields supplement the market growth even more. Moreover, surge in potential application of exosomes in cancer diagnosis and development of translational precision medicines are expected to create lucrative opportunities in the industry.

Covid-19 scenario-

Rapid spread of Covid-19 heightened the need for molecular diagnosis, thus impacting the global exosome diagnostic and therapeutic market positively.
This trend is pretty likely to continue till the pandemic is completely over.

The diagnostic segment to dominate by 2030-

Based on application, the diagnostic segment accounted for more than two-thirds of the global exosome diagnostic and therapeutic market share in 2020, and is anticipated to rule the roost by 2030. The same segment would also cite the fastest CAGR of 29.5% throughout the forecast period, due to rise in incidence of chronic disease and surge in demand for early diagnosis.

Specific Requirement on COVID-19? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/1723

The instrument segment to maintain the lion's share-

Based on product, the instrument segment held nearly three-fifths of the global exosome diagnostic and therapeutic market revenue in 2020, and is expected to lead the trail by 2030. This is owing to increase in need for molecular diagnosis and surge in R&D activities for the purpose of diagnosis. The software segment, on the other hand, would manifest the fastest CAGR of 30.2% from 2020 to 2030. This is attributed to advancements in R&D activities in the healthcare sector and increase in number of key manufacturers across the world.

North America garnered the major share in 2020-

Based on region, North America held the major share in 2020, generating nearly two-fifths of the global exosome diagnostic and therapeutic market, due to rise in product launches for exosome therapeutics, surge in the presence of key players, and development of R&D activities in the pharmaceutical and biopharmaceutical sector across the province. Asia-Pacific, however, would grow at the fastest CAGR of 30.3% by 2030. Increase in the prevalence of chronic and infectious disorders, growth in health care expenditures, and surge in demand for molecular diagnosis drive the market growth in the region.

Key players in the industry-

Exosome Diagnostics Inc.
NanoSomix Inc.
Thermo Fisher Scientific Inc.
Malvern Instruments Ltd.
System Biosciences Inc.
NX Pharmagen
Aethlon Medical, Inc.
Sistemic Inc.

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

"We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market."

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Remote Patient Monitoring Market - Global Opportunity Analysis and Industry Forecast, 2020–2030

Pharmaceutical Packaging Market - Global Opportunity Analysis and Industry Forecast, 2020-2030

Pulse Oximeters Market - Global Opportunity Analysis and Industry Forecast, 2020-2030

Ophthalmic Lasers Market - Global Opportunity Analysis and Industry Forecast, 2020–2030

Molecular Diagnostics Market - Global Opportunity Analysis and Industry Forecast, 2020–2030

Forensic Technology Market - Global Opportunity Analysis and Industry Forecast, 2020–2030

Medical Device Coatings Market - Global Opportunity Analysis and Industry Forecast, 2020–2030

Women's Health Diagnostics Market - Global Opportunity Analysis and Industry Forecast, 2020–2030

AI in Healthcare Market - Global Opportunity Analysis and Industry Forecast, 2020–2030

Gene Therapy Market - Global Opportunity Analysis and Industry Forecast, 2020–2030

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
[email protected]
Web: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on LinkedIn: https://www.linkedin.com/showcase/life-sciences-industry-research/